Kornitzer Capital Management Inc Merck & Co., Inc. Transaction History

Kornitzer Capital Management Inc

$5.21 Billion
Q3 2024

A detailed history of Kornitzer Capital Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 548,181 shares of MRK stock, worth $52.9 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares

548,181

Previous 546,890 0.24%

Holding current value

$52.9 Million

Previous $67.7 Million 8.05%

% of portfolio

1.2%

Previous 1.33%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$111.15 - $128.97 $143,494 - $166,500	1,291 Added 0.24%	548,181 $62.3 Million
Q2 2024 Aug 02, 2024	BUY	$123.8 - $132.96 $210,583 - $226,164	1,701 Added 0.31%	546,890 $67.7 Million
Q1 2024 May 01, 2024	SELL	$113.24 - $131.95 $920,867 - $1.07 Million	-8,132 Reduced 1.47%	545,189 $71.9 Million
Q4 2023 Jan 31, 2024	SELL	$100.18 - $109.02 $530,453 - $577,260	-5,295 Reduced 0.95%	553,321 $60.3 Million
Q3 2023 Oct 31, 2023	SELL	$102.95 - $114.33 $617 - $685	-6 Reduced -0.0%	558,616 $57.5 Million
Q2 2023 Aug 01, 2023	SELL	$108.61 - $118.38 $258,600 - $281,862	-2,381 Reduced 0.42%	558,622 $64.5 Million
Q1 2023 May 09, 2023	SELL	$102.94 - $114.86 $413,407 - $461,277	-4,016 Reduced 0.71%	561,003 $59.7 Million
Q4 2022 Feb 02, 2023	SELL	$87.44 - $112.11 $297,121 - $380,949	-3,398 Reduced 0.6%	565,019 $62.7 Million
Q3 2022 Nov 03, 2022	SELL	$84.53 - $94.96 $710,390 - $798,043	-8,404 Reduced 1.46%	568,417 $49 Million
Q2 2022 Aug 03, 2022	SELL	$83.49 - $94.64 $345,648 - $391,809	-4,140 Reduced 0.71%	576,821 $52.6 Million
Q1 2022 Apr 27, 2022	BUY	$73.51 - $82.4 $127,907 - $143,376	1,740 Added 0.3%	580,961 $47.7 Million
Q4 2021 Feb 01, 2022	BUY	$72.28 - $90.54 $7,372 - $9,235	102 Added 0.02%	579,221 $44.4 Million
Q3 2021 Nov 03, 2021	BUY	$71.68 - $78.83 $13,045 - $14,347	182 Added 0.03%	579,119 $43.5 Million
Q2 2021 Jul 30, 2021	BUY	$70.31 - $77.77 $439,085 - $485,673	6,245 Added 1.09%	578,937 $45 Million
Q1 2021 Apr 30, 2021	BUY	$68.86 - $81.11 $1.01 Million - $1.19 Million	14,624 Added 2.62%	572,692 $44.1 Million
Q4 2020 Jan 29, 2021	SELL	$71.77 - $79.65 $310,764 - $344,884	-4,330 Reduced 0.77%	558,068 $45.7 Million
Q3 2020 Oct 30, 2020	SELL	$73.18 - $82.95 $933,045 - $1.06 Million	-12,750 Reduced 2.22%	562,398 $46.7 Million
Q2 2020 Aug 03, 2020	SELL	$70.42 - $80.13 $159,078 - $181,013	-2,259 Reduced 0.39%	575,148 $44.5 Million
Q1 2020 Apr 30, 2020	SELL	$63.36 - $87.82 $769,824 - $1.07 Million	-12,150 Reduced 2.06%	577,407 $44.4 Million
Q4 2019 Jan 31, 2020	SELL	$77.58 - $87.54 $1.62 Million - $1.83 Million	-20,854 Reduced 3.42%	589,557 $53.6 Million
Q3 2019 Nov 04, 2019	SELL	$76.08 - $82.93 $1.32 Million - $1.44 Million	-17,310 Reduced 2.76%	610,411 $51.4 Million
Q2 2019 Jul 31, 2019	SELL	$69.84 - $81.59 $998,362 - $1.17 Million	-14,295 Reduced 2.23%	627,721 $52.6 Million
Q1 2019 May 01, 2019	SELL	$69.58 - $79.36 $515,518 - $587,978	-7,409 Reduced 1.14%	642,016 $53.4 Million
Q4 2018 Jan 31, 2019	SELL	$65.24 - $75.71 $560,085 - $649,970	-8,585 Reduced 1.3%	649,425 $49.6 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $241,721 - $284,249	-4,190 Reduced 0.63%	658,010 $46.7 Million
Q2 2018 Aug 02, 2018	SELL	$50.83 - $59.72 $2.74 Million - $3.22 Million	-53,916 Reduced 7.53%	662,200 $40.2 Million
Q1 2018 Apr 30, 2018	SELL	$50.96 - $59.23 $972,062 - $1.13 Million	-19,075 Reduced 2.59%	716,116 $39 Million
Q4 2017 Jan 31, 2018	SELL	$51.62 - $61.64 $4.45 Million - $5.32 Million	-86,245 Reduced 10.5%	735,191 $41.4 Million
Q3 2017 Oct 31, 2017	BUY	$58.67 - $63.13 $48.2 Million - $51.9 Million	821,436	821,436 $52.6 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $245B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account

Kornitzer Capital Management Inc Merck & Co., Inc. Transaction History